Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients

NCT02019524 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

FED

Sponsor class

Conditions

Breast Cancer
Ovarian Cancer

Interventions

BIOLOGICAL: E39 peptide vaccine
BIOLOGICAL: E39 vaccine then J65 vaccine
BIOLOGICAL: J65 vaccine then E39 vaccine

Sponsor

COL George Peoples, MD, FACS

Collaborators

[object Object]